The risk of epileptic seizures after craniotomy is extremely important but the incidence of postoperative epilepsy varies greatly, depending on the patient's conditions such as primary diseases, severity of surgical insult, and pre-existing epilepsy. Animal studies suggest that neurosurgical insults lead to seizures by two different mechanisms: One mechanism is mediated by free radical generation and the other by impaired ion balance across the cell membrane caused by ischemia or hypoxia. Conventional antiepileptic agents such as phenytoin, phenobarbital, carbamazepine, and valproic acid are promising for the prevention of early seizures, but the effect in preventing postoperative epilepsy is still controversial. Studies on the prophylactic effect of newer antiepileptic agents in craniotomized patients were very limited. Zonisamide, an antiepileptic agent with antiepileptogenic, free radical scavenging and neuroprotective actions in experimental animals, showed promising effects against postoperative epilepsy in a randomized double blind controlled trial. Prophylactic treatment for craniotomized patients significantly prevented the development of partial seizures during the follow-up period. Most recent studies have not supported the prophylactic use of antiepileptic agents in craniotomized patients, but further studies are required.
Introduction
The World Health Organization has defined of epilepsy as``a chronic brain disorder of various etiologies due to excessive discharge of cerebral neurons.'' This definition indicates that epilepsy is caused by various types of insults to the brain, such as head trauma, brain tumor, cerebrovascular disease, and/or damage secondary to intracranial surgery.
Posttraumatic epilepsy has been extensively investigated as a good model to clarify the pathophysiology of epilepsy, as the time of occurrence is easily determined. Seizures after intracranial surgery have received less attention than posttraumatic epilepsy, because the background pathology of postoperative seizures is more complex than that of posttraumatic epilepsy: craniotomized patients have various fundamental diseases; the extent of surgical insult differs; and some patients also had a history of preoperative epileptic seizures.
The efficacy of anticonvulsant prophylaxis in the management of head injury and in patients after craniotomy is controversial, but the optimum postoperative management for seizure is very important to avoid unexpected complications, and to improve the postoperative outcome.
This article reviews the epidemiology and pathogenesis of postoperative seizures, and assesses the prophylactic use of antiepileptic agents. We also discuss the promising results of our study on the prophylactic effect of a newer antiepileptic agent, zonisamide, in craniotomized patients.
Epidemiology of Postoperative Seizures I. Time scale of the risk of postoperative seizure
Postoperative seizures are divided into three categories by the time interval following injury: postoperative immediate seizures occurring within 24 hours, early seizures within 1 week, and late seizures 1 week or more after the craniotomy. 28) Only late seizures are considered to be true epilepsy, since the epileptic focus has been formed. Therefore, the term``postoperative epilepsy'' indicates late seizures in this review. An analysis of 877 patients who had no prior history of epilepsy revealed that development of postoperative seizures decreases with time: the maximum incidence of postoperative epilepsy occurred within the first 3 months, and three quarters of all patients who developed seizures experienced the initial seizure within 1 year. Only 8% had the initial seizure more than 2 years after surgery. 12) The time course of development of postoperative seizures is similar to that of posttraumatic epilepsy. In a study of 109 men with head injury sustained in the Korean conflict, 70% of patients with seizures experienced their first seizure by 1 year and 90% by 2 years after injury. 5) As new patients with seizures appeared, earlier patients ceased having seizures. Within 5 to 10 years, one half of the patients had become seizurefree irrespective of medication. In the population at risk, 65% to 75% never had a seizure (Fig. 1) .
II. Risk of postoperative seizures
The risk of epileptic seizure following intracranial surgery is well recognized. The actual incidence of postoperative epilepsy is not clear, because of the multiplicity of pathologies and variety of operative procedures. The overall incidence of postoperative epilepsy was 17% in a study of 1000 patients who had undergone supratentorial neurosurgery with prolonged follow up. 69) The incidence varied with different pathologies ranging from 3% for Frazier's operation to 92% for abscess as shown in Table 1 .
III. Postoperative early seizures
There are pathophysiological differences between posttraumatic early seizures and postoperative early seizures. Patients with head injury do not harbor epileptic foci in the brain during the early stage following injury, whereas some patients who received craniotomy have pre-existing epileptic foci. Late seizures developed in 41% of the patients who had postoperative early seizures, 69) so postoperative early seizure seems to increase the risk of postoperative epilepsy.
Immediate or early seizures occurred in 4.3% of patients who received craniotomy within 24 hours. 38) The overall incidence of immediate convulsion after craniotomy was 3.0%, and 77.5% of patients developed convulsions within 6 hours after operation in a study of 1293 patients with aneurysm. 24) IV. Operative approach The seizure incidence in 511 patients after Treatment of Postoperative Seizures posterior fossa surgery was 5.9% within 2 weeks postoperatively. 72) Seizure incidence was higher in the sitting position than in the prone or lateral position, probably due to venous air embolism and/or pneumocephalus, suggesting that the operation position is critical to prevent seizures after posterior fossa surgery. Ventricular shunting procedures are associated with a widely varying incidence, ranging from 2% to 47%. 6, 8, 9) Infection of the system was associated with a higher risk. 8, 9) Therefore, surgeons should avoid infection of the system to reduce the risk.
V. Intracranial tumor
Postoperative seizures developed in about 25% of 163 patients with meningioma 39) and seven of 43 patients with glioblastoma, 74) none of whom had had no preoperative epilepsy. A comparative study showed a higher incidence of postoperative seizure in patients with preoperative seizures (27/50, 54%) than in patients without preoperative seizures (11/140, 8%), suggesting that preoperative seizure is a significant risk factor for postoperative seizures. 22) Surgical treatment stopped seizures in 62.7% of 59 patients with meningioma who had experienced preoperative seizures 40) and in 66% of 29 patients with glioblastoma. 74) VI. Chronic subdural hematoma (CSH)
The incidence of postoperative seizures associated with surgical treatment of CSH varies from 3.6% to 18.5%. 56, 66) The surgical technique was thought to be responsible for the occurrence of seizures. 56) 
VII. Arteriovenous malformation (AVM)
The incidence of de novo and ongoing postoperative seizures following supratentorial cerebral AVM resection remains controversial. Onset of new seizures was observed in 12 (9.3%) of 129 patients with AVM who had not experienced seizures before surgery. 35) Thirty-five (52.2%) of 67 patients with preoperative epilepsy experienced no seizures for more than 2 years after surgery and 20 of them were receiving no antiepileptic medication. Among 32 patients (47.8%) who continued to have seizures, the frequency of seizures decreased in 10, remained unchanged in 18, and increased in four patients. The risk of persistent epilepsy after surgery is small in those patients who had not had preoperative epilepsy, and that preoperative epilepsy tended to greatly improve after excision of the AVM. Incidences of postoperative seizures after excision of AVM ranged from 5.9% to 50.0% (Table 2) . 35) 
VIII. Intracranial aneurysm
Generally, intracranial aneurysm is located in the subarachnoid and extracerebral spaces. Therefore, aneurysms per se do not contribute to epileptogenic-
ity. Uneventful surgery carries no risk for seizures, especially in patients with non-ruptured aneurysm. Actually, cisternal clot due to bleeding from aneurysms, vasospasm, surgical insult, and ferrous ion from blood facilitate pre-or postoperative seizures. Table 3 summarizes the incidences of postoperative seizures associated with aneurysm. The overall incidence of postoperative seizure was 13.2% (292/2217), but the incidence varied between 3.0% and 42.1%. Ruptured aneurysm associated with intracerebral hematoma seems to be the critical factor to increase risk of seizures (Table 3) . 61, 65) 
Pathogenesis of Seizures After Craniotomy
Neurosurgical insults may lead to early and late seizures by two different mechanisms, which are closely linked. One mechanism may be mediated by free radical generation mainly caused by extravascular leakage of blood components, and the other may be mediated by disturbance of ion balance across cell membrane caused by ischemia or hypoxia. Topical application of a free radical generating system, such as alumina gel 37) or iron salt, 81) into brain tissue induced seizures in experimental animals. Pretreatment with antioxidants suppressed the iron-induced formation of epileptogenic focus in rats, first suggesting the involvement of free radicals in development of posttraumatic epilepsy. 81) Insults to the brain cause extravasations of erythrocytes, with hemolysis and deposition of hemoglobin in the tissue. Iron liberated from hemoglobin reacts with hydrogen peroxide in surrounding tissues and generate free radicals, which in turn leads to early seizure and epileptogenic focus formation. In fact, topical application of hemoglobin into the brain caused massive generation of free radicals and epilepsy-like discharges in rats. 48) The mechanism underlying development of seizure and epileptogenic foci may involve free radicals. Hydrogen peroxide decreased gammaaminobutyric acid-mediated inhibitory neuronal activity in cortical and thalamic neurons, and increased excitatory transmission in thalamic neurons in vitro, indicating free radicals can promote hyperexcitability of the thalamocortical circuit by altering the balance between excitation and inhibition. 16 ) Repeated exposure to free radicals may lead to the formation of epileptogenic foci, like a kindling process. Free radical formation was observed in kindling models in vitro 18) and in vivo. 17) Another mechanism underlying postoperative seizures is the disturbance of ion balance caused by cerebral ischemia or hypoxia. High energy reserves such as adenosine triphosphate decrease in ischemic or hypoxic conditions, which in turn leads to disturbances in the ion balance across the cell membrane, as the ratio of intracellular to extracellular concentration of K ＋ ions decreases and that of Na ＋ ions increases. This imbalance decreases neuronal hyperpolarization that may result in immediate or early seizures. Imbalance of Na ＋ ions is considered to primarily mediate Ca ＋ ＋ -independent glutamate efflux in ischemia. 50) Calcium influx under ischemic or hypoxic conditions is also critical for postoperative seizures. Calcium-dependent processes have pivotal roles in the early efflux of glutamate occurring immediately after the onset of ischemia. 50) Furthermore, increased levels of intracellular Ca ＋ ＋ accompany the epileptiform events in various model systems. 2, 70) Prolonged elevation of intracellular Ca ＋ ＋ levels during an ischemic insult also triggers free radical generation. 15) The above observations suggest that free radical formation, disturbance of ion balance, and release of excitatory amino acids caused by insults to the brain act synergistically to promote postoperative seizures.
Approach to Prevention of Postoperative Seizures
I. Pharmacological treatment after craniotomy Pharmacological treatment of postoperative epilepsy: There have been several studies on the prophylactic effect of conventional antiepileptic agents such as phenytoin, phenobarbital, carbamazepine, and valproic acid for postoperative seizures, but no definite conclusion has been obtained. 69) Prophylactic use of antiepileptic agents reduced the incidence of epileptic seizures in the phenytointreated group (12.9%) compared to the placebo group (18.4%) in 281 patients who underwent craniotomy, 52) suggesting the prophylactic use of antiepileptic agents in patients at risk of higher than 15% of developing postoperative seizures.
No reduction was found in the incidence of seizures in 102 high-risk patients given carbamazepine or phenytoin. 12) Antiepileptic agent treatment was found to be often ineffective, and the prophylactic treatment should be discontinued after 6 months if patients had had no preoperative seizures. 60) The prophylactic effect of antiepileptic agents may depend on the severity of surgical insult or of fundamental disease. We found that if the preoperative grade of ruptured aneurysm is good and surgery proceeds uneventfully, the incidence of postopera-
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tive seizures is very low, but some patients suffer from severe brain damage due to subarachnoid hemorrhage. Antiepileptic agents may be beneficial for prevention of seizures in patients after surgery of aneurysms. 31, 53, 54) However, the risk of postoperative epilepsy is low in such patients. 4, 58, 67) Therefore, unconditional prophylactic use of antiepileptic agents should be avoided in patients with cerebral aneurysms, and restricted for patients with high risk for epileptic seizures, such as patients with aneurysm of the middle cerebral artery, large intracerebral hematoma, postoperative spasm with late ischemic infarction, or shunt-dependent hydrocephalus. 31) Similarly, the prophylactic effect of antiepileptic agents in patients receiving surgery on CSH is obscure due to the low incidence of postoperative seizures in such patients.
A meta-analysis on 30 studies published between 1980 and 1995 revealed that antiepileptic agents tended to prevent postoperative seizures in patients who underwent supratentorial craniotomies, though the effect was not statistically significant (p ＝ 0.1). 36) Pharmacological treatment of early postoperative seizures: The use of antiepileptic agents may alter the incidence of seizures during a particular time period. Phenytoin given prophylactically was effective only between Days 7 and 70 postoperatively. 52) Comment on pharmacological treatment after craniotomy: Conventional antiepileptic agents seem to be promising for the prevention of early seizures after craniotomy, but the usefulness in preventing postoperative epilepsy remains controversial. Postoperative epilepsy, i.e., recurrent seizures in the late phase after craniotomy, may be a consequence of epileptogenic focus formation. Therefore, the controversy about the effect of conventional antiepileptic agents may be, at least in part, attributable to their weak action against epileptogenic focus formation, although suppression of early seizures by conventional antiepileptic agents may contribute to suppression of subsequent epileptogenic focus formation. Phenytoin and carbamazepine were reported to have no preventive effect on epileptogenic focus formation in kindling animals. 79) Phenobarbital and valproic acid blocked kindling, and were suggested as antiepileptogenic agents. 79) However, phenobarbital and valproic acid failed to provide prophylaxis of late posttraumatic epilepsy in clinical studies. 41, 75) The newer agents, lamotrigine 71) and felbamate 71) had neuroprotective effects, and topiramate 80) and levetiracetam 42) suppressed epileptiform activity in experimental animals. However, few clinical studies have investigated the prophylactic effect of newer agents on postoperative epilepsy, except for zonisamide. Therefore, clinical trials are awaited on the prophylactic effect on postoperative seizures.
II. Prevention of postoperative seizures by zonisamide
Zonisamide, one of the newer antiepileptic agents, has broad spectral antiepileptic and antiepileptogenic actions, 43) as well as free radical scavenging 34, 76) and neuroprotective actions. 46, 59) Free radicals and neuronal cell death are also considered to be causes of epileptogenic focus formation. 82) Furthermore, zonisamide is useful for prophylaxis of epilepsy after intracranial surgery. 84) Therefore, a randomized controlled multicenter trial was conducted to assess the preventive effect of zonisamide for postoperative epilepsy. 49) Methods of the zonisamide study: The study was carried out in a double blind controlled manner with the cooperation of 41 neurosurgical institutions in Japan. Two hundred seventy-eight patients who underwent craniotomy for brain tumor, cerebral vascular disease, or brain trauma were allocated to the zonisamide-treated group or the phenobarbitaltreated group.
Phenobarbital was used as the reference drug because: inactive placebo is ethically difficult to administer to patients; the results could be compared to the preceding study on the prophylactic effect of phenobarbital, 41) and phenobarbital can prevent early seizures in patients with poor compliance because of the long half-life in the blood.
The drugs were administered from at least 1 week before the surgery at a dose of 200 mg zonisamide or 80 mg phenobarbital, and then the dose was increased to 300 mg zonisamide or 120 mg phenobarbital in the 2nd to 4th weeks. The doses of test drugs were adjusted according to the plasma concentrations of the test drugs and subsequent occurrence of adverse reactions, with maximum doses of 400 mg for zonisamide and 160 mg for phenobarbital. The drugs were administered for 1 year, and then the doses were gradually decreased to zero during the half-year secession period. The total study period was 3 years, as patients were followed up for 2 years including the secession period.
Results of the zonisamide study: Two hundred fifty-five of 278 registered patients were analyzed, excluding 23 patients who violated the protocol. Two hundred nineteen patients completed the 3-year study (112 in the zonisamide group and 107 in the phenobarbital group). The patient characteristics are shown in Table 4 . No statistical differences were found between the zonisamide-and phenobarbital-treated groups in sex, age, disease history, surgery procedure, surgical invasion, or previous history of epilepsy or seizure type before surgery. Seizures occurring 1 month or longer after surgery were considered to be postoperative seizure in this study. During the period between 1 month and 12 months after the medication, 5.9% of patients experienced epileptic seizures (15/255). The incidence of epileptic seizures in the zonisamide-treated group was 5.4% and that in the phenobarbital-treated group was 6.8%. There were no statistical differences between the two groups (Table 5) .
During the 2 years of follow up, the incidence of epileptic seizures was 12.1% in the phenobarbitaltreated group and 7.1% in the zonisamide-treated group (p ＝ 0.164) as shown in Table 6 . Simple and complex partial seizures developed in six of the 107 patients in the phenobarbital-treated group, but in none of the 112 patients in the zonisamide-treated group (p ＝ 0.013). In patients with meningioma, the incidence of epileptic seizures during the follow-up period in the phenobarbital-treated group (6/37, 16.2%) was higher than that in the zonisamidetreated group (1/40, 2.5%) (p ＝ 0.0507). The incidence of adverse drug reactions was 27.9% (39/129) in the zonisamide-treated group and 23.8% (20/125) in the phenobarbital-treated group. Comment on the zonisamide study: The study demonstrated the prophylactic effect of zonisamide on partial seizures in the follow-up period, although the incidence of seizures in the medication period was similar in the zonisamide-and phenobarbitaltreated groups. Such findings can be explained as follows: Incidences of seizures in the medication period were similar because both drugs have similar antiepileptic effects on postoperative epilepsy; and the significantly lower incidence of partial seizures in the zonisamide-treated group during the followup period is attributable to the antiepileptogenic action of zonisamide, whereas phenobarbital does not have such action. In other words, zonisamide has a true prophylactic effect on postoperative epileptic seizures, but the effect is not complete. Therefore, once an epileptic focus has been formed, secondary generalized seizures occurred in both the zonisamide-and phenobarbital-treated groups.
The incidence of adverse events in the zonisamide-treated group was 27.9% in this study. A large-scale open study of zonisamide in Japan with 1008 epileptic patients found adverse events in 51.3%. 83) The most common adverse events were drowsiness (24%), ataxia (13%), anorexia (11%), Treatment of Postoperative Seizures gastrointestinal symptoms (7%), decrease in spontaneity (6%), and psychomotor slowing (5%). Less common but clinically relevant adverse events include renal calculi, oligohidrosis, cognitive dysfunction, and weight loss, and rare but potentially life-threatening adverse events include skin and hematological disorders. Pharmacological basis of the efficacy of zonisamide against postoperative seizures: Zonisamide has a benzisoxazole structure, and shows broad spectral antiepileptic activity in patients with both partial and generalized seizures, including seizures refractory to other antiepileptic agents. 83) Zonisamide has anticonvulsant activity in various experimental models. Zonisamide was effective against tonic clonic seizures induced by maximal electroshock but ineffective against clonic seizures induced by pentylenetetrazol in rats. 44) Zonisamide reduced the duration of cortical focal seizures induced by electrical stimulation of the visual cortex in cats, 26) and suppressed both interictal spikes and the secondary generalized seizures produced by cortical application of tungstic acid in rats or by cortical freezing in cats. 25) Zonisamide also suppressed the convulsive seizures induced by kindling in the cortex, hippocampus, or amygdala, or in kainic acid-induced limbic seizures. 30, 73) These experimental results also indicate the antiepileptogenic effect of zonisamide. Zonisamide also has free radial scavenging and neuroprotective actions as described in detail later. These actions are also likely to contribute to the prevention of epileptogenic focus formation.
Proposal of Evidence-based Guidelines for Prevention of Postoperative Seizures I. Rationale for prophylactic use of antiepileptic agents in craniotomized patients
Conventional antiepileptic agents can prevent early seizures, but the effect on postoperative late epilepsy remains controversial. General opinion is moving against the prophylactic effect of antiepileptic agents on posttraumatic and/or postoperative epileptic seizures, reducing such use in neurosurgical practice. However, we would like to emphasize the necessity of using antiepileptic agents in craniotomized patients based on following three effects: Most antiepileptic agents suppress postoperative early seizure, most antiepileptic agents act as a neuroprotectant, and some antiepileptic agents inhibit postoperative epilepsy. The randomized controlled trial of zonisamide on postoperative epilepsy 49) demonstrated the prophylactic effect of zonisamide on partial seizures. As zonisamide has these three effects, administration is suitable for the management of postoperative seizure.
Prevention of early seizure after craniotomy: Early seizures induced by brain damage after craniotomy or trauma can cause cerebral ischemia and enhance brain edema, resulting in disastrous complications such as aggravation of cerebral herniation, consciousness loss and paresis, and retardation of postoperative recovery. Therefore, early seizures should be reduced if the patient is subjected to invasive neurosurgery. The prophylactic effect of antiepileptic agents on early postoperative seizures would be very valuable in such cases. 7, 14, 68) Cerebral protective action of antiepileptic agents: A surgical insult to the brain causes free radical formation and delayed neuronal damage, which is linked to epileptogenic focus formation. The seizure also generates free radicals that in turn damage neuronal cells. Therefore, it is important to protect brain from damage to prevent postoperative early seizure and the formation of epileptogenic foci. In general, antiepileptic agents have cerebral 1) Administration of antiepileptic agents should be considered in the following cases: ・Patients with a previous history of epileptic seizures ・Patients with considerable cerebral damage ・Patients with early postoperative seizures 2) Choice of antiepileptic agents ・Conventional antiepileptic agents are available ・Zonisamide is recommended because of its favorable pharmacological and pharmacokinetic properties 3) Timing of antiepileptic agent administration ・Antiepileptic agent administration should be started before surgery in high-risk patients ・Parenteral phenobarbital or phenytoin can be used during the perioperative period 4) Termination of antiepileptic agent administration ・Antiepileptic agent administration can be terminated within several months in patients without major invasion of the brain ・Antiepileptic agent administration should be continued for around 2 years in patients with considerable damage of the brain ・Standard epilepsy management should be adopted if postoperative seizures develop protective action, 21) because this class of agents suppress cation movement across cell membranes and stabilize the membranes, thereby protecting the brain from hypoxia or ischemia. 23) In view of the cerebral protective action, the effect of zonisamide is very interesting. Zonisamide has neuroprotective action in various models of ischemia or hypoxia. 46, 59) Zonisamide exerts this neuroprotective action by two mechanisms: a mechanism independent from its anticonvulsant action 46) and another dependent on anticonvulsant mechanism like other conventional antiepileptic agents. The former mechanism of zonisamide may be based on its free radical scavenging action, because the brain response to trauma or other injury appears to be mediated at least in part by free radical formation. Zonisamide scavenges the 1,1-dephenyl-2-picrylhydroxyl radical, hydroxyl radical and nitric oxide in vitro and in vivo. 34, 51) Oral administration of zonisamide, at clinically relevant doses, prevents the increase of lipid peroxide and 8-hydroxy-2'-deoxyguanosine, indicators of oxidative stress, induced by topical application of ferric chloride in rat cerebral cortex. 33) Effect of antiepileptic agents on immunity: The influence of antiepileptic agents on cellular immunity should be considered, especially in postoperative management of brain tumors. Phenytoin suppressed part of the cellular immune functions such as lymphocyte proliferation, natural killer activity, and cytotoxic T lymphocyte activity, and phenobarbital suppressed the proliferative response to interleukin-2 and cytotoxic T lymphocyte activity, but valproic acid suppressed no cellular immune activities. 57) Zonisamide also does not suppress any of the cellular immune activity examined. 32) II. Guidelines for prevention of postoperative epilepsy (Fig. 2 ) Indication for postoperative antiepileptic agent administration: There is no definite agreement about which patients should be treated with antiepileptic agents, and which antiepileptic agents should be used. Administration of antiepileptic agents should be considered in the following cases: Patients who have a previous history of epileptic seizures; patients who are expected to suffer from cerebral damage sufficient to cause seizures, for example, patients who have relatively long-term impairment of consciousness, localized neurological symptoms, cerebral contusion, or cerebral hemorrhage; and patients who have early postoperative seizure.
Choice of antiepileptic agents for postoperative seizure management: Conventional antiepileptic agents can prevent early seizure after craniotomy and are expected to suppress the development of postoperative epilepsy to some extent. Zonisamide is suitable for patients who have high risks for early and late postoperative seizures. The pharmacokinetic properties of zonisamide are favorable for clinical use, as absorption is rapid and virtually complete, the half-life is relatively long, and protein binding is low. 27, 45) The long half-life of zonisamide enables once-a-day administration, which facilitates good compliance.
Timing of antiepileptic agent administration: If there is a risk for postoperative seizures, antiepileptic agent administration should be started as soon as possible, because of the relatively long period required to attain their steady-state blood concentrations after starting medication. For example, zonisamide (200 mg/day or more) should be given at least 1 week before surgery with monitoring of the plasma concentration (therapeutic range 10-30 mg/ml). 84) If the patient cannot take oral medication during the perioperative period, or if the patient does not take oral medication prior to the surgery, parenteral administration of phenobarbital or phenytoin can be used. Therefore, the following regimen is recommended: intravenous loading dose Treatment of Postoperative Seizures of 15 mg/kg of phenytoin followed by postoperative treatment, 39) or two infusions of phenytoin (mean dosage of 18 mg/kg, mean time of 1 hr) perioperatively and during the first postoperative day. 11) Termination of antiepileptic agent administration: Administration of antiepileptic agents can be terminated within several months after the surgery in patients with craniotomy without major invasion to the brain, or if preoperative epilepsy is not present. If the patient has considerable damage to the brain but no postoperative seizures, administration should be continued for around 2 years and then the dose should gradually be decreased. In patients who have had seizures, the timing for withdrawal of medications follows the standard of general epilepsy management. If the patients have been seizure-free for more than 2 years and show no epileptic discharge on electroencephalography, withdrawal of antiepileptic agent medication should be considered, because the recurrence of seizures significantly decreases 2 or 3 years after final attack. Care should be taken to terminate medication in patients who have been seizure-free for more than 2 years but still have epileptic discharges, because seizures are often recurrent in such patients.
